![Uciane Scarlett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uciane Scarlett
Presidente presso
T-Cypher Bio Ltd.
Profilo
Uciane Scarlett is currently the Executive Chairman at T-Cypher Bio Ltd. and the Principal at MPM BioImpact LLC and Oxford Science Enterprises PLC.
Previously, she worked as the Director of Business Development & Strategy at Compass Therapeutics, Inc. from 2016 to 2018 and as an Associate at Atlas Venture Advisors, Inc. from 2018 to 2019.
Dr. Scarlett obtained her undergraduate degree from the University of The West Indies Mona in 2005 and her doctorate from Dartmouth Medical School in 2011.
Posizioni attive di Uciane Scarlett
| Società | Posizione | Inizio |
|---|---|---|
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Investitore di Private Equity | 01/12/2019 |
T-Cypher Bio Ltd.
 T-Cypher Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Presidente | - |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Investitore di Private Equity | 01/01/2021 |
Precedenti posizioni note di Uciane Scarlett
| Società | Posizione | Fine |
|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Analista di Private Equity | 30/11/2019 |
| COMPASS THERAPEUTICS, INC. | Investitore di Private Equity | 02/01/2018 |
Formazione di Uciane Scarlett
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
University of The West Indies Mona
 University of The West Indies Mona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
 Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Finance |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
T-Cypher Bio Ltd.
T-Cypher Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
